ESR1 and neoplasm: One possible explanation for the lack of effect for the anti-estrogens could be that the tumor-initiating subpopulation of cancer stem cells are mainly ERα-negative and will therefore not be targeted by conventional anti-estrogen therapies in ERα-positive cancer9,10.